BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 30523270)

  • 1. Piwi-like 1 and -2 protein expression levels are prognostic factors for muscle invasive urothelial bladder cancer patients.
    Eckstein M; Jung R; Weigelt K; Sikic D; Stöhr R; Geppert C; Agaimy A; Lieb V; Hartmann A; Wullich B; Wach S; Taubert H
    Sci Rep; 2018 Dec; 8(1):17693. PubMed ID: 30523270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of GP88 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Is an Independent Prognostic Factor for Bladder Cancer Patients.
    Eckstein M; Lieb V; Jung R; Sikic D; Weigelt K; Stöhr R; Geppert C; Weyerer V; Bertz S; Serrero G; Yue B; Hartmann A; Wullich B; Taubert H; Wach S
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCL2 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Shows Divergent Prognostic Potential for Bladder Cancer Patients Depending on Lymph Node Stage.
    Eckstein M; Epple E; Jung R; Weigelt K; Lieb V; Sikic D; Stöhr R; Geppert C; Weyerer V; Bertz S; Kehlen A; Hartmann A; Wullich B; Taubert H; Wach S
    Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32429318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Piwil 2 expression is correlated with disease-specific and progression-free survival of chemotherapy-treated bladder cancer patients.
    Taubert H; Wach S; Jung R; Pugia M; Keck B; Bertz S; Nolte E; Stoehr R; Lehmann J; Ohlmann CH; Stöckle M; Wullich B; Hartmann A
    Mol Med; 2015 May; 21(1):371-80. PubMed ID: 25998509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GATA3 immunohistochemistry in urothelial carcinoma of the upper urinary tract as a urothelial marker and a prognosticator.
    Inoue S; Mizushima T; Fujita K; Meliti A; Ide H; Yamaguchi S; Fushimi H; Netto GJ; Nonomura N; Miyamoto H
    Hum Pathol; 2017 Jun; 64():83-90. PubMed ID: 28428106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic stratification of muscle invasive urothelial carcinomas using limited immunohistochemical panel of Gata3 and cytokeratins 5/6, 14 and 20.
    Jangir H; Nambirajan A; Seth A; Sahoo RK; Dinda AK; Nayak B; Kaushal S
    Ann Diagn Pathol; 2019 Dec; 43():151397. PubMed ID: 31494492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triple-marker immunohistochemical assessment of muscle-invasive bladder cancer: Is there prognostic significance?
    Labban M; Najdi J; Mukherji D; Abou-Kheir W; Tabbarah A; El-Hajj A
    Cancer Rep (Hoboken); 2021 Apr; 4(2):e1313. PubMed ID: 33538412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GATA binding protein 3 is down-regulated in bladder cancer yet strong expression is an independent predictor of poor prognosis in invasive tumor.
    Miyamoto H; Izumi K; Yao JL; Li Y; Yang Q; McMahon LA; Gonzalez-Roibon N; Hicks DG; Tacha D; Netto GJ
    Hum Pathol; 2012 Nov; 43(11):2033-40. PubMed ID: 22607700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Piwi-like 1 protein expression is a prognostic factor for renal cell carcinoma patients.
    Stöhr CG; Steffens S; Polifka I; Jung R; Kahlmeyer A; Ivanyi P; Weber F; Hartmann A; Wullich B; Wach S; Taubert H
    Sci Rep; 2019 Feb; 9(1):1741. PubMed ID: 30741998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The PIWI protein acts as a predictive marker for human gastric cancer.
    Wang Y; Liu Y; Shen X; Zhang X; Chen X; Yang C; Gao H
    Int J Clin Exp Pathol; 2012; 5(4):315-25. PubMed ID: 22670175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In stage pT1 non-muscle-invasive bladder cancer (NMIBC), high KRT20 and low KRT5 mRNA expression identify the luminal subtype and predict recurrence and survival.
    Breyer J; Wirtz RM; Otto W; Erben P; Kriegmair MC; Stoehr R; Eckstein M; Eidt S; Denzinger S; Burger M; Hartmann A;
    Virchows Arch; 2017 Mar; 470(3):267-274. PubMed ID: 28074276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SNAI1 protein expression is an independent negative prognosticator in muscle-invasive bladder cancer.
    Keck B; Wach S; Goebell PJ; Kunath F; Bertz S; Lehmann J; Stöckle M; Taubert H; Wullich B; Hartmann A
    Ann Surg Oncol; 2013 Oct; 20(11):3669-74. PubMed ID: 23807662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of immunohistochemistry-based subtyping of GATA3, CK20, CK5/6, and CK14 expression on survival after radical cystectomy for muscle-invasive bladder cancer.
    Bejrananda T; Kanjanapradit K; Saetang J; Sangkhathat S
    Sci Rep; 2021 Oct; 11(1):21186. PubMed ID: 34707176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemistry of cytokeratin (CK) 5/6, CD44 and CK20 as prognostic biomarkers of non-muscle-invasive papillary upper tract urothelial carcinoma.
    Jung M; Kim B; Moon KC
    Histopathology; 2019 Feb; 74(3):483-493. PubMed ID: 30286252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune Cell-Associated Protein Expression Helps to Predict Survival in Muscle-Invasive Urothelial Bladder Cancer Patients after Radical Cystectomy and Optional Adjuvant Chemotherapy.
    Taubert H; Eckstein M; Epple E; Jung R; Weigelt K; Lieb V; Sikic D; Stöhr R; Geppert C; Weyerer V; Bertz S; Kehlen A; Hartmann A; Wullich B; Wach S
    Cells; 2021 Jan; 10(1):. PubMed ID: 33467469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and predictive value of lymph-specific markers in urothelial carcinoma of the bladder.
    von Hardenberg J; Martini T; Knauer A; Ströbel P; Becker A; Herrmann E; Schubert C; Steidler A; Bolenz C
    Urol Oncol; 2014 Jan; 32(1):54.e9-17. PubMed ID: 24360666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of GATA binding protein-3 expression in primary lung adenocarcinoma.
    Hashiguchi T; Miyoshi H; Nakashima K; Yokoyama S; Matsumoto R; Murakami D; Mitsuoka M; Takamori S; Akagi Y; Ohshima K
    Hum Pathol; 2017 May; 63():157-164. PubMed ID: 28322854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological significance of GATA3, cytokeratin 20, cytokeratin 5/6 and p53 expression in muscle-invasive bladder cancer.
    Wang CC; Tsai YC; Jeng YM
    PLoS One; 2019; 14(8):e0221785. PubMed ID: 31469885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical assessment of basal and luminal markers in non-muscle invasive urothelial carcinoma of bladder.
    Rodriguez Pena MDC; Chaux A; Eich ML; Tregnago AC; Taheri D; Borhan W; Sharma R; Rezaei MK; Netto GJ
    Virchows Arch; 2019 Sep; 475(3):349-356. PubMed ID: 31300876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of heme oxygenase-1, S100 calcium-binding protein A4, and syndecan-1 expression in primary non-muscle-invasive bladder cancer.
    Kim JH; Park J
    Hum Pathol; 2014 Sep; 45(9):1830-8. PubMed ID: 24957789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.